The University of Southern California Research Center for Liver Diseases, funded since 1995, has the goal of fostering and facilitating interdisciplinary research in liver and digestive disease. The Center has 41 members and 22 affiliated members. The Biomedical Research Base consists of four major Themes supported by 58 peer-reviewed grants totaling $10.1 million in annual direct costs. These Themes include: a) viral hepatitis, hepatocellular and colon cancer: b) liver injury: c) cell biology, signal transduction and transport: d) regulatory biology: liver metabolism, gene expression, and liver/intestinal growth and development. Four core facilities support this Research Base: 1) Administrative Core which oversees the operations and budget of the Center including the Cores, P/F program and enrichment program, 2) Cell Culture Core, which provides isolated and primary cultured rat, mouse and human hepatocytes and various cell lines;3) Cell and Tissue Imaging Core, which consists of two subcores: Microscopy Subcore, which provides confocal and fluorescence microscopy using various platforms, and Histology Subcore, which provides liver tissue slide preparation, routine and special staining, and interpretation. 3) Analytical, Metabolic, Instrumentation Core, which consists of a base Core and two subcores;the base core provides oversight of the subcores and access to a wide range of equipment shared by Center members and specialized HPLC analyses;the Small Molecule Subcore (metabolic component) provides quantitation of analytes using mass spectrometry, and the Proteomic Subcore uses state-of-the-art mass spectrometry approaches for protein identification. The Center supports Pilot Feasibility projects in diverse areas related to the themes of the Research Base. Current projects include studies of: a) farnesoid X receptor, bile acids and liver regeneration;b) the role of Myc-max and Mnt-max in regulation of p53 and cyclin D1 by toxic bile acid;c) salvage of short bowel syndrome by tissue engineered intestine;d) development of a model for engraftment of human embryonic stem cell-derived hepatocytes to regenerate liver;and e) elucidation of the role of AP-1 and DNA damage repair in HCV-induced hepatocelluar carcinoma.

Public Health Relevance

Liver diseases are a major cause of death and health-related problems. The USC Research Center for Liver Diseases focuses on basic and translational research to unravel the mechanisms and potential prevention and treatment of the most prevalent liver diseases, namely acute and chronic viral hepatitis, medication and alcohol induced liver disease, fatty liver disease, cirrhosis, and liver cancer.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK048522-20
Application #
8616052
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (M1))
Program Officer
Podskalny, Judith M,
Project Start
1997-03-01
Project End
2015-02-28
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
20
Fiscal Year
2014
Total Cost
$1,167,215
Indirect Cost
$446,712
Name
University of Southern California
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Matsushita, Noriko; Hassanein, Mohamed T; Martinez-Clemente, Marcos et al. (2017) Gender difference in NASH susceptibility: Roles of hepatocyte Ikk? and Sult1e1. PLoS One 12:e0181052
Tomita, Kyoko; Kohli, Rohit; MacLaurin, Brittany L et al. (2017) Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis. JCI Insight 2:
Elmasry, Sandra; Wadhwa, Sanya; Bang, Bo-Ram et al. (2017) Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation. Gastroenterology 152:550-553.e8
Lee, Amy S; Brandhorst, Sebastian; Rangel, Daisy F et al. (2017) Effects of Prolonged GRP78 Haploinsufficiency on Organ Homeostasis, Behavior, Cancer and Chemotoxic Resistance in Aged Mice. Sci Rep 7:40919
Sakiyama, Ryoichi; Blau, Brandon J; Miki, Toshio (2017) Clinical translation of bioartificial liver support systems with human pluripotent stem cell-derived hepatic cells. World J Gastroenterol 23:1974-1979
Alonso, Cristina; Fernández-Ramos, David; Varela-Rey, Marta et al. (2017) Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis. Gastroenterology 152:1449-1461.e7
Pyzik, Michal; Rath, Timo; Kuo, Timothy T et al. (2017) Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury. Proc Natl Acad Sci U S A 114:E2862-E2871
Moeini, Aida; Machida, Hiroko; Takiuchi, Tsuyoshi et al. (2017) Association of Nonalcoholic Fatty Liver Disease and Venous Thromboembolism in Women With Endometrial Cancer. Clin Appl Thromb Hemost 23:1018-1027
Johnson, Sandra A S; Lin, Justin J; Walkey, Christopher J et al. (2017) Elevated TATA-binding protein expression drives vascular endothelial growth factor expression in colon cancer. Oncotarget 8:48832-48845
Dhandhukia, Jugal P; Li, Zhe; Peddi, Santosh et al. (2017) Berunda Polypeptides: Multi-Headed Fusion Proteins Promote Subcutaneous Administration of Rapamycin to Breast Cancer In Vivo. Theranostics 7:3856-3872

Showing the most recent 10 out of 434 publications